Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.


Journal

Progress in lipid research
ISSN: 1873-2194
Titre abrégé: Prog Lipid Res
Pays: England
ID NLM: 7900832

Informations de publication

Date de publication:
04 2021
Historique:
received: 17 03 2021
revised: 22 04 2021
accepted: 23 04 2021
pubmed: 30 4 2021
medline: 27 5 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

Despite encouraging progresses achieved in the management of viral diseases, efficient strategies to counteract infections are still required. The current global challenge highlighted the need to develop a rapid and cost-effective strategy to counteract the SARS-CoV-2 pandemic. Lipid metabolism plays a crucial role in viral infections. Viruses can use the host lipid machinery to support their life cycle and to impair the host immune response. The altered expression of mevalonate pathway-related genes, induced by several viruses, assures survival and spread in host tissue. In some infections, statins, HMG-CoA-reductase inhibitors, reduce cholesterol in the plasma membrane of permissive cells resulting in lower viral titers and failure to internalize the virus. Statins can also counteract viral infections through their immunomodulatory, anti-inflammatory and anti-thrombotic effects. Beyond statins, interfering with the mevalonate pathway could have an adjuvant effect in therapies aimed at mitigating endothelial dysfunction and deregulated inflammation in viral infection. In this review we depicted the historical and current evidence highlighting how lipid homeostasis and mevalonate pathway targeting represents a valid approach to rapidly neutralize viruses, focusing our attention to their potential use as effective targets to hinder SARS-CoV-2 morbidity and mortality. Pros and cons of statins and Mevalonate-pathway inhibitors have been also dissected.

Identifiants

pubmed: 33915202
pii: S0163-7827(21)00015-1
doi: 10.1016/j.plipres.2021.101099
pmc: PMC8074527
pii:
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Hypolipidemic Agents 0
Mevalonic Acid S5UOB36OCZ

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101099

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Références

Lancet Rheumatol. 2020 Oct;2(10):e594-e602
pubmed: 32864628
Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245
pubmed: 31848472
Cell Metab. 2020 Aug 4;32(2):176-187.e4
pubmed: 32592657
Pharmacol Ther. 2018 May;185:34-49
pubmed: 29127024
Curr Opin Immunol. 2002 Feb;14(1):111-6
pubmed: 11790540
AIDS. 2016 Jan;30(2):171-83
pubmed: 26645604
Cell Rep. 2013 Oct 31;5(2):323-30
pubmed: 24120862
Cell. 2008 Jul 11;134(1):97-111
pubmed: 18614014
Front Immunol. 2018 Jun 04;9:1276
pubmed: 29915602
PLoS One. 2007 May 23;2(5):e470
pubmed: 17520029
Mol Cell Biol. 2012 Dec;32(24):5035-45
pubmed: 23045399
PLoS Pathog. 2015 Dec 9;11(12):e1005332
pubmed: 26650119
Bone. 2011 Jul;49(1):42-9
pubmed: 21281748
J Virol. 2012 Mar;86(6):2942-9
pubmed: 22258239
J Am Med Dir Assoc. 2020 Jul;21(7):909-914.e2
pubmed: 32674818
Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2341-2348
pubmed: 31463620
AIDS Res Hum Retroviruses. 2017 Feb;33(2):126-132
pubmed: 27618139
J Exp Med. 2004 Aug 16;200(4):541-7
pubmed: 15314078
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4960-5
pubmed: 15041742
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259
pubmed: 32347925
J Virol. 2005 Sep;79(17):11496-500
pubmed: 16103200
Am J Cardiol. 2020 Nov 1;134:153-155
pubmed: 32891399
Clin Cancer Res. 2007 Dec 1;13(23):6947-58
pubmed: 18056169
J Exp Med. 2011 Jul 4;208(7):1511-22
pubmed: 21708931
J Exp Med. 2002 Aug 5;196(3):293-301
pubmed: 12163558
PLoS Pathog. 2009 Feb;5(2):e1000295
pubmed: 19214220
Biomed Res Int. 2014;2014:872370
pubmed: 25478576
Antiviral Res. 2014 May;105:92-9
pubmed: 24613180
Virology. 2017 Oct;510:234-241
pubmed: 28750327
Blood Purif. 2017;43(1-3):91-96
pubmed: 27951534
Chem Rev. 2011 Oct 12;111(10):5922-43
pubmed: 21766791
Annu Rev Immunol. 2012;30:271-94
pubmed: 22224770
PLoS One. 2017 Jan 12;12(1):e0170123
pubmed: 28081264
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7777-82
pubmed: 16682645
Cell Death Dis. 2019 Nov 21;10(12):880
pubmed: 31754207
Cell Res. 2020 Apr;30(4):285-299
pubmed: 31974523
Nature. 2002 Nov 7;420(6911):78-84
pubmed: 12422218
Crit Care. 2020 Jul 14;24(1):429
pubmed: 32664990
World J Hepatol. 2015 Oct 28;7(24):2535-42
pubmed: 26527170
Front Immunol. 2017 Nov 27;8:1664
pubmed: 29230226
Curr Opin Cell Biol. 2017 Aug;47:24-33
pubmed: 28242560
PLoS One. 2013 Aug 21;8(8):e72324
pubmed: 23991091
Cardiovasc Drugs Ther. 2019 Oct;33(5):625-639
pubmed: 31773344
HIV Clin Trials. 2003 May-Jun;4(3):164-9
pubmed: 12815556
Lancet Respir Med. 2018 Sep;6(9):691-698
pubmed: 30078618
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15625-15634
pubmed: 31308239
J Am Heart Assoc. 2018 Oct 2;7(19):e009835
pubmed: 30371340
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):e38-e81
pubmed: 30580575
Front Pharmacol. 2021 Jan 19;11:579548
pubmed: 33542685
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1195-1197
pubmed: 31044331
Transplantation. 2008 May 15;85(9):1311-7
pubmed: 18475189
J Virol. 2004 Nov;78(21):12062-5
pubmed: 15479847
PLoS Biol. 2016 Mar 03;14(3):e1002364
pubmed: 26938778
Cell Res. 2020 Nov;30(11):1043-1045
pubmed: 32811977
Nat Immunol. 2005 Apr;6(4):345-52
pubmed: 15785760
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):396-404
pubmed: 25514794
AIDS. 2009 Mar 13;23(5):555-65
pubmed: 19238075
Virology. 2009 Jun 20;389(1-2):8-19
pubmed: 19419745
Crit Care. 2009;13(6):R201
pubmed: 20003352
N Engl J Med. 2014 Jun 5;370(23):2191-200
pubmed: 24835849
Pharmacol Res. 2017 May;119:128-136
pubmed: 28179205
Arch Med Sci. 2020 Apr 25;16(3):490-496
pubmed: 32399094
Cell Metab. 2017 Jul 5;26(1):131-141
pubmed: 28683280
J Lipid Res. 2014 Feb;55(2):226-38
pubmed: 24296663
Future Virol. 2012 Aug;7(8):801-818
pubmed: 23420457
Med Microbiol Immunol. 2015 Jun;204(3):395-407
pubmed: 25800350
J Clin Invest. 2006 Mar;116(3):607-14
pubmed: 16511593
Nat Immunol. 2013 May;14(5):489-99
pubmed: 23563690
J Immunol. 2008 Oct 1;181(7):4485-94
pubmed: 18802051
Antimicrob Agents Chemother. 2001 Apr;45(4):1231-7
pubmed: 11257039
Nature. 2013 Jul 25;499(7459):485-90
pubmed: 23812589
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1225-1229
pubmed: 32683320
Am J Case Rep. 2020 Aug 17;21:e926733
pubmed: 32801291
Proc Am Thorac Soc. 2004;1(2):115-20
pubmed: 16113423
Ochsner J. 2010 Spring;10(1):16-21
pubmed: 21603349
Lipids Health Dis. 2020 Sep 7;19(1):204
pubmed: 32892746
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10666-71
pubmed: 24994901
Trends Microbiol. 2011 Jul;19(7):368-75
pubmed: 21530270
Nat Metab. 2020 Feb;2(2):142-152
pubmed: 32500117
Pharmacol Rep. 2021 Jun;73(3):769-780
pubmed: 33608850
Br J Pharmacol. 2020 Nov;177(21):4873-4886
pubmed: 32562276
J Virol. 2006 May;80(9):4521-7
pubmed: 16611912
AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1009-19
pubmed: 11485618
Sci Rep. 2016 Jul 19;6:29842
pubmed: 27431907
Medicine (Baltimore). 2015 Feb;94(6):e462
pubmed: 25674734
PLoS One. 2013 May 13;8(5):e63263
pubmed: 23675468
PLoS One. 2011;6(10):e25997
pubmed: 22022489
Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):93-99
pubmed: 30298219
Viruses. 2010 Apr;2(4):1011-1049
pubmed: 21994669
Cell. 2018 Nov 1;175(4):1059-1073.e21
pubmed: 30270039
Ann Oncol. 2006 Jun;17(6):897-907
pubmed: 16547070
Virology. 2013 Aug 1;442(2):132-47
pubmed: 23642566
BMC Biol. 2019 Jul 18;17(1):59
pubmed: 31319842
Hepatology. 2006 Jul;44(1):117-25
pubmed: 16799963
Transpl Infect Dis. 2015 Aug;17(4):536-43
pubmed: 25989423
J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204
pubmed: 32675661
Immunity. 2008 Apr;28(4):468-76
pubmed: 18400189
Mol Med Rep. 2014 Jan;9(1):51-6
pubmed: 24154548
FASEB J. 2019 Aug;33(8):9516-9525
pubmed: 31125254
J Crit Care. 2013 Oct;28(5):571-6
pubmed: 23618779
Nat Rev Immunol. 2010 Jul;10(7):514-26
pubmed: 20577268
J Infect Dis. 2011 Mar 15;203(6):756-64
pubmed: 21325137
PLoS Pathog. 2019 Sep 13;15(9):e1008030
pubmed: 31518366
Postgrad Med J. 2022 May;98(1159):354-359
pubmed: 33541927
Am J Cardiol. 2020 Dec 1;136:171-173
pubmed: 32991850
J Biol Chem. 2006 Nov 17;281(46):35446-53
pubmed: 16963439
Immunity. 2007 Sep;27(3):384-92
pubmed: 17892847
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
PLoS Pathog. 2009 Oct;5(10):e1000636
pubmed: 19851468
Clin Pharmacokinet. 2013 Oct;52(10):815-31
pubmed: 23703578
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1068-1069
pubmed: 32405159
PLoS One. 2015 Apr 17;10(4):e0122646
pubmed: 25884398
Cell Immunol. 2010;264(1):71-7
pubmed: 20483407
Nat Commun. 2019 Jan 10;10(1):120
pubmed: 30631056
Ther Adv Musculoskelet Dis. 2017 Jan;9(1):22-34
pubmed: 28101146
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E197-E202
pubmed: 32501731
Pharmacol Res. 2020 Jun;156:104803
pubmed: 32289478
Cell Microbiol. 2015 Jan;17(1):45-50
pubmed: 25287059
Nature. 1997 Oct 16;389(6652):737-42
pubmed: 9338786
Gastroenterology. 2011 Jan;140(1):144-52
pubmed: 20833169
Nat Rev Drug Discov. 2005 Dec;4(12):977-87
pubmed: 16341063
J Clin Invest. 2002 May;109(9):1125-31
pubmed: 11994399
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32
pubmed: 22390970
PLoS Pathog. 2016 May 06;12(5):e1005610
pubmed: 27152966
J Immunol. 2012 Dec 15;189(12):5924-33
pubmed: 23129753
J Clin Med. 2020 Jun 18;9(6):
pubmed: 32570882
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Science. 1994 Aug 26;265(5176):1237-40
pubmed: 7520605
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
HIV Clin Trials. 2014 Jan-Feb;15(1):1-13
pubmed: 24518210
Osteoporos Int. 2020 Sep;31(9):1633-1644
pubmed: 32206852
Virology. 2003 Sep 15;314(1):253-60
pubmed: 14517078
Antimicrob Agents Chemother. 2007 Aug;51(8):2965-8
pubmed: 17562808
Sci Rep. 2019 Aug 7;9(1):11461
pubmed: 31391514
Circ Res. 2013 Jun 7;112(12):1592-601
pubmed: 23519695
Nat Rev Immunol. 2018 Nov;18(11):669
pubmed: 30297717
Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):410-411
pubmed: 32529218
BMJ Open. 2019 Feb 13;9(2):e022897
pubmed: 30765397
Signal Transduct Target Ther. 2020 Sep 3;5(1):186
pubmed: 32883951
Cell. 2015 Dec 17;163(7):1716-29
pubmed: 26686653
J Mol Med (Berl). 2019 Jul;97(7):927-936
pubmed: 31020340
AIDS. 2011 May 15;25(8):1128-31
pubmed: 21422984
Biomed Pharmacother. 2007 Aug;61(7):400-7
pubmed: 17643927
Clin Infect Dis. 2020 Oct 23;71(7):1655-1663
pubmed: 31621838
Cell Host Microbe. 2010 Nov 18;8(5):422-32
pubmed: 21075353
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1613-1615
pubmed: 32882643
Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):637-640
pubmed: 33593686
Immunol Rev. 2011 May;241(1):260-8
pubmed: 21488902
Emerg Infect Dis. 2020 Jun;26(6):
pubmed: 32441242
J Transl Med. 2020 Jun 29;18(1):261
pubmed: 32600410
Virology. 2008 Nov 25;381(2):215-21
pubmed: 18814896
Int J Infect Dis. 2015 Jul;36:80-4
pubmed: 26143190
Nature. 2007 Oct 18;449(7164):819-26
pubmed: 17943118
Biochem Pharmacol. 2020 Aug;178:114114
pubmed: 32579957
Int J Infect Dis. 2013 Nov;17(11):e1069-70
pubmed: 23725984
ACS Comb Sci. 2020 Jun 8;22(6):297-305
pubmed: 32402186
Biochem Biophys Res Commun. 2006 Aug 18;347(1):51-9
pubmed: 16824485
Hepatology. 2007 Jan;45(1):257
pubmed: 17187410
Antiviral Res. 2010 Jun;86(3):241-5
pubmed: 20211652
Cureus. 2020 Apr 6;12(4):e7561
pubmed: 32382463
Nat Med. 2003 Feb;9(2):213-9
pubmed: 12524534
AIDS. 2016 Oct 23;30(16):2469-2476
pubmed: 27753678
Med Hypotheses. 2020 Oct;143:110127
pubmed: 32759008
Lancet Infect Dis. 2008 Sep;8(9):571-6
pubmed: 18420459
mBio. 2018 May 1;9(3):
pubmed: 29717011
Cell Rep. 2019 Jun 4;27(10):2948-2961.e7
pubmed: 31167140
Int J Mol Sci. 2020 May 17;21(10):
pubmed: 32429572
Trends Immunol. 2016 Dec;37(12):819-830
pubmed: 27692616
Front Pharmacol. 2020 Mar 20;11:274
pubmed: 32265698
Nat Immunol. 2013 Sep;14(9):893-900
pubmed: 23959186
Arq Bras Cardiol. 2021 Jan;116(1):147-152
pubmed: 33566980
J Orthop. 2020 Jun 02;21:287-290
pubmed: 32523258
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32105-32113
pubmed: 33239446
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31573980
J Clin Oncol. 2012 Feb 20;30(6):623-30
pubmed: 22271485
J Viral Hepat. 2006 Jul;13(7):441-8
pubmed: 16792537
Emerg Infect Dis. 2020 Jul;26(7):1618-1620
pubmed: 32197060
Cell. 2004 Oct 15;119(2):299-309
pubmed: 15479645
Ann Hepatol. 2020 Jul - Aug;19(4):353-358
pubmed: 32425991
Front Immunol. 2019 Mar 06;10:360
pubmed: 30894857
Int J Mol Med. 2014 Jul;34(1):61-73
pubmed: 24788303
Annu Rev Immunol. 2003;21:483-513
pubmed: 12543936
Hepatology. 2017 Sep;66(3):896-907
pubmed: 28318053
Endocrine. 2021 Feb;71(2):270-272
pubmed: 33219496
N Engl J Med. 2014 Oct 30;371(18):1695-703
pubmed: 25268516
Cell Microbiol. 2014 Oct;16(10):1493-502
pubmed: 25131438
Nat Rev Immunol. 2014 Nov;14(11):731-43
pubmed: 25324126
Biol Blood Marrow Transplant. 2019 May;25(5):1011-1021
pubmed: 30537551
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):e175-e182
pubmed: 33535790
Nat Commun. 2021 Feb 26;12(1):1325
pubmed: 33637713

Auteurs

Maria Chiara Proto (MC)

Department of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.

Donatella Fiore (D)

Department of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.

Chiara Piscopo (C)

Department of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.

Cristina Pagano (C)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", 80131 Naples, Italy.

Mario Galgani (M)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", 80131 Naples, Italy; Institute of Endocrinology and Experimental Oncology, IEOS CNR, 80131 Naples, Italy.

Sara Bruzzaniti (S)

Institute of Endocrinology and Experimental Oncology, IEOS CNR, 80131 Naples, Italy; Department of Biology, University of Naples "Federico II", 80126 Naples, Italy.

Chiara Laezza (C)

Institute of Endocrinology and Experimental Oncology, IEOS CNR, 80131 Naples, Italy.

Patrizia Gazzerro (P)

Department of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy. Electronic address: pgazzerro@unisa.it.

Maurizio Bifulco (M)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", 80131 Naples, Italy. Electronic address: maubiful@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH